de Cremoux, P., Biard, L., Poirot, B., Bertheau, P., Teixeira, L., Lehmann-Che, J., . . . Groheux, D. (2018). (18)FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients. Oncotarget.
Dyfyniad Arddull Chicagode Cremoux, Patricia, et al. "(18)FDG-PET/CT and Molecular Markers to Predict Response to Neoadjuvant Chemotherapy and Outcome in HER2-negative Advanced Luminal Breast Cancers Patients." Oncotarget 2018.
Dyfyniad MLAde Cremoux, Patricia, et al. "(18)FDG-PET/CT and Molecular Markers to Predict Response to Neoadjuvant Chemotherapy and Outcome in HER2-negative Advanced Luminal Breast Cancers Patients." Oncotarget 2018.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.